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Background: RAGE receptor plays a critical role in many inflammatory disorders.
Results: Functional interaction between RAGE and DAP10 coordinately regulates S100A8/A9-mediated cell survival.
Conclusion: DAP10 membrane adaptor is critically involved in RAGE-mediated survival signaling upon S100A8/A9 binding.
Significance: This is the first report demonstrating that RAGE-mediated survival signaling is critically regulated by DAP10
interaction.
The receptor for advanced glycation end products (RAGE) is
involved in the pathogenesis of many inflammatory, degenera-
tive, and hyperproliferative diseases, including cancer. Previ-
ously, we revealed mechanisms of downstream signaling from
ligand-activated RAGE, which recruits TIRAP/MyD88. Here,
we showed that DNAX-activating protein 10 (DAP10), a trans-
membrane adaptor protein, also binds to RAGE. By artificial
oligomerization of RAGE alone or RAGE-DAP10, we found that
RAGE-DAP10 heterodimer formation resulted in a marked
enhancement ofAkt activation,whereas homomultimeric inter-
action of RAGE led to activation of caspase 8. Normal human
epidermal keratinocytes exposed to S100A8/A9, a ligand for
RAGE, at a nanomolar concentrationmimicked thepro-survival
response of RAGE-DAP10 interaction, although at a micro-
molar concentration, the cells mimicked the pro-apoptotic
response of RAGE-RAGE. In transformed epithelial cell lines,
A431 and HaCaT, in which endogenous DAP10 was overex-
pressed, and S100A8/A9, even at a micromolar concentration,
led to cell growth and survival due to RAGE-DAP10 interaction.
Functional blocking ofDAP10 in the cell lines abrogated theAkt
phosphorylation from S100A8/A9-activated RAGE, eventually
leading to an increase in apoptosis. Finally, S100A8/A9, RAGE,
and DAP10 were overexpressed in the psoriatic epidermis. Our
findings indicate that the functional interaction between RAGE
and DAP10 coordinately regulates S100A8/A9-mediated sur-
vival and/or apoptotic response of keratinocytes.
The receptor for advanced glycation end products (RAGE)2
is involved in diverse physiological and pathological processes
related to inflammation (1–5). RAGE binds to a wide variety of
ligands, including advanced glycation end products, S100
proteins, amyloid , and high mobility group box protein 1
(HMGB1) (6). Upon binding of ligands, RAGE triggers different
intracellular signaling pathways (7, 8). One of the mechanisms
for the complex signal processing involving RAGE is sharing of
ligands by RAGE and other receptors. For example, advanced
glycation end products also bind to galectin-3, fasciclin, EGF-
like, laminin-type EGF-like, and link domain-containing scav-
enger receptor-1 (FEEL1), fasciclin, EGF-like, laminin-type
EGF-like, and link domain-containing scavenger receptor-2
(FEEL2), cluster of differentiation 36 (CD36), scavenger recep-
tor class A, scavenger receptor class B member 1, and lectin-
type oxidizedLDL receptor 1 (LOX-1) (9–14), whereas amyloid
 and HMGB1 bind to Toll-like receptors (TLRs) (15, 16), and
S100A8/A9 binds to Emmprin (17).
S100A8/A9, one of the 20 S100 proteins, plays a pivotal role
in the skin through RAGE (5, 18). Zenz et al. (19) showed that
induction of S100A8/A9 is one of the earliest events in the
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pathogenesis of psoriasis in a mouse model. In addition, serum
S100A8/A9 was increased in patients with psoriasis vulgaris
and general pustular psoriasis (20), and S100A8/A9 was shown
to stimulate the growth of normal human keratinocytes
(NHKs) (18).
An additional mechanism is interference among receptors
and adaptor proteins. We recently found that, upon ligand
binding, RAGE recruits TIRAP and MyD88, well known adap-
tor proteins for TLR2 and -4, for downstream signal transduc-
tion (21). At the same time, RAGE and TLR4 have unique
adaptor proteins, diaphanous 1 and TRIF-related adaptor
molecule/TRIF, respectively (22, 23).
Zong et al. (24) reported that homodimerization of RAGE is
essential for RAGE-mediated signal transduction, leading
to activations of p44/p42 MAPK (ERK1/2) and NF-B in
HEK293T cells.Moreover, Slowik et al. (25) showed that formyl
peptide receptors, to which amyloid- can bind, interact with
RAGE and augment the enhanced signal transduction of
ERK1/2 in HEK293 cells. However, Emmprin and TLR2/4 do
not directly interact with RAGE.3
In this study, we tried to identify possible receptors and
transmembrane adaptor proteins that interact with RAGE,
with a focus on immune response and inflammation.We found
that DNAX-activating protein 10 (DAP10), a transmembrane
adaptor protein for natural killer group 2,memberD (NKG2D),
directly binds to RAGE and modulates the S100A8/A9-trig-
gered signaling pathway. DAP10 as well as S100A8/A9 and
RAGE were overexpressed in psoriatic epidermis.
EXPERIMENTAL PROCEDURES
Reagents—The following reagents were purchased from
commercial sources: B/B homodimerizer and A/C hetero-
dimerizer, Clontech; Akt inhibitor, Calbiochem-EMD Milli-
pore; recombinant human TGF-, Sigma; recombinant human
EGF, TNF-, and IL-17, PeproTech EC (London, UK); recom-
binant human IL-22, R&D Systems (Minneapolis, MN); triti-
ated thymidine, ARC (St. Louis, MO); and FITC-labeled
annexin V, MBL (Nagoya, Japan).
Cell Culture—Neonatal normal human epidermal keratino-
cytes (KURABO, Osaka, Japan) were cultured in serum-free
154S medium (KURABO) containing HKGS growth supple-
ment (KURABO) and used for experiments between passages 2
and 4. HaCaT, a gift from Dr. Fusenig (German Cancer
Research Center, Heidelberg, Germany), A431 (ATCC, Rock-
ville, MD), and HEK293T (RIKEN Bio Resource Center, Tsu-
kuba, Japan) were cultured inD/Fmedium (Invitrogen) supple-
mented with 10% fetal bovine serum (FBS; Intergen, Purchase,
NY). For quantitation of apoptosis, the fluorescence intensity of
annexin V-labeled cells was determined using a fluorescence
microplate reader (Fluoroskan Ascent FL; Thermo Fisher Sci-
entific Inc., Waltham, MA). For cross-linking of endogenous
RAGE, BS3 (Sulfo-DSS; Thermo Scientific) was applied to cells
according to the protocol reported previously (24).
Vector Constructs for Expression in Mammalian Cells—
cDNAs were inserted into the pIDT-CMVi vector (21). A total
of seven fragments (SP-V-C1-C2-TM, SP-V-TM, SP-C1-TM,
SP-C2-TM, SP-V-C1-TM, SP-C1-C2-TM, and SP-V-C1-C2)
from the full-length RAGE (SP-V-C1-C2-TM-cyt) was con-
structed for expression as C-terminal (Myc-HA-FLAG-His6)-
tagged forms. (SP indicates signal peptide sequence (1–22
amino acids); V indicates variable (V)-type immunoglobulin
domain (23–132 amino acids); C1 indicates constant (C)-type
immunoglobulin domain 1 (133–243 amino acids); C2 indi-
cates C-type immunoglobulin domain 2 (244–342 amino
acids); TM indicates hydrophobic transmembrane-spanning
domain (343–363 amino acids); and cyt indicates short cyto-
plasmic domain (364–404 amino acids).) Human cDNAs
encoding full-length TLR4, TNFR1, TNFR2, DAP10/HCST
(DAP10; WT and mut Y86F), c/common -chain/IL2RG/
CD132 (c), and gp130/IL6ST/CD130 (gp130) were designed
for expression as C-terminal 3FLAG-His6-tagged forms.
Nine kinds of Src homology 2 (SH2) domain-containing adap-
tor proteins (PI3K-p85, growth factor receptor-bound protein
2) (GRB2), growth factor receptor-bound protein 7 (GRB7),
NCK1, NCK2, CRK, SOCS, SHC, and SHP2) were tagged with
C-terminal 3Myc-His6-tagged forms.
For regulated dimerization/polymerization, we used an
iDimerizeTM-inducible expression system (Clontech TAKARA)
that allows specific interaction by treatment with dimerizers as
follows: 1) transfection with DmrB-DmrB-RAGE-cyt (364–
404 amino acids)-3HA-His6 followed by B/B homodimerizer
treatment for homopolymerization of RAGE; 2) transfection
with DmrA-DmrB-RAGE-cyt-3HA-His6, and DmrC-DmrB-
RAGE-cyt-3FLAG-His6 followed by A/C heterodimerizer
treatment for RAGE homodimerization; and 3) transfection
with DmrA-DmrB-RAGE-cyt-3HA-His6 and DmrC-DmrB-
DAP10-cyt (70–93 amino acids)-3FLAG-His6 followed by
A/C heterodimerizer treatment for RAGE-DAP10 het-
erodimerization. The proteins have amyristylation signal at the
N-terminal site. FuGENE-HD (Promega BioSciences, San Luis
Obispo, CA) was used for transfection.
Preparation of S100A8/A9 Proteins—Human S100A8 and
S100A9 cDNAs were cloned into the pGEX-6P1 vector (GE
Healthcare) for expression in Escherichia coli. Purification and
heterodimerization of S100A8/A9 were performed under con-
ditions reported previously (17, 18, 21). The amounts of con-
taminating endotoxins (LPS and -glucans) were 0.008 EU/mg
for S100A8/A9 and 0.013 EU/mg for GST as determined with a
Limulus amebocyte lysate assay (Seikagaku Corp., Tokyo,
Japan).
Western Blot (WB) Analysis and Immunoprecipitation (IP)—
WB analysis was performed under conventional conditions.
The following antibodies were used for Western blot analysis:
mouse anti-human DAP10, mouse anti-human RAGE (A-9),
and rabbit anti-human PKC antibodies (Santa Cruz Biotech-
nology, Santa Cruz, CA); rabbit anti-human phospho-PKC-
(Thr-560) antibody (Epitomics Abcam, Burlingame, CA);
mouse anti-HA tag (clone 6E2), mouse anti-Myc tag (clone
9B11), rabbit anti-human p38, rabbit anti-human phospho-p38
(Thr-180/Tyr-182), rabbit anti-human Akt, rabbit anti-human
phospho-Akt (Ser-473), rabbit anti-human phospho-Akt
3 M. Sakaguchi, H. Murata, Y. Aoyama, T. Hibino, E. W. Putranto, I. M. W. Ruma,
Y. Inoue, Y. Sakaguchi, K.-i. Yamamoto, R. Kinoshita, J. Futami, K. Kataoka, K.
Iwatsuki, and N-.h Huh, unpublished data.
DAP10 Has a Critical Role in RAGE-mediated Survival Signal
23390 JOURNAL OF BIOLOGICAL CHEMISTRY VOLUME 289•NUMBER 34•AUGUST 22, 2014
 at Tsushim
a, Shikata and K
urashiki Cam
pus, O
kayam
a U
niversity on A
ugust 7, 2017
http://w
w
w
.jbc.org/
D
ow
nloaded from
 
(Thr308), rabbit anti-human NF-B(p65), rabbit anti-human
phospho-NFB(p65) (Ser-536), mouse anti-human cleaved
caspase 8 (Asp-384), andmouse anti-phosphotyrosine (Tyr(P)-
102) antibodies (Cell Signaling Technology, Beverly, MA); rab-
bit anti-humanTIRAP antibody (Abcam,Cambridge, UK); rab-
bit anti-human MyD88 and mouse anti-human PI3K (p85)
antibodies (MBL, Nagoya, Japan); and mouse anti-FLAG tag
(clone M2) and mouse anti-human tubulin antibodies (Sigma).
Rabbit anti-human phospho-RAGE (Ser-391) antibody was
obtained by ordering from a custom antibody production ser-
vice at MBL (the immunized phosphopeptide was AELNQS-
(phospho)EEPEC).
For immunohistochemical analysis, the following antibodies
were used: mouse anti-human calprotectin antibody (S100A8/
A9 heterodimer) (Hycult Biotech, Plymouth Meeting, PA);
mouse anti-human RAGE (A-9) antibody (Santa Cruz Biotech-
nology); mouse anti-human DAP10 antibody (Santa Cruz Bio-
technology); and rabbit anti-human phospho-Akt (Ser-473)
antibody (Epitomics Abcam).
For pulldown analysis of endogenous RAGE, rabbit anti-hu-
man RAGE (H-300) antibody (Santa Cruz Biotechnology) was
biotinylated using a Biotin labeling kit-SH (Dojindo Molecular
Technologies, Rockville, MD) to recover antibody-free RAGE
after IP using streptavidin-agarose (21). The second antibody
was horseradish peroxidase-conjugated anti-mouse or anti-
rabbit IgG antibody (Cell Signaling Technology). Positive sig-
nals were detected by a chemiluminescence system (ECL Plus;
GE Healthcare).
Monoclonal anti-HA (clone HA-7) tag-agarose (Sigma),
monoclonal anti-Myc tag (clone 1G4)-agarose (MBL), and
streptavidin-agarose (Invitrogen) were used for co-IP experi-
ments. The levels of the GTP-bound forms of Rac1 and Cdc42
were determined by using a Rac/Cdc42 activation assay kit
(Millipore).
Immunohistochemistry—Human skin sampleswere obtained
after receiving written informed consent under conditions
approved by the Research Ethics Committee of Okayama Uni-
versity Medical School Hospital, Japan. Paraffin sections were
subjected to autoclaving (121 °C for 20 min) in sodium citrate
buffer, followed by treatment with L.A.B solution (Poly-
sciences,Warrington, PA) at room temperature for 30min. The
sections were incubated first with antibodies, followed by treat-
ment with highly cross-adsorbed Alexa Fluor 594-conjugated
(for S100A8/A9 and RAGE) or Alexa Fluor 488 (for DAP10)-
conjugated goat anti-mouse IgG antibodies and Alexa Fluor
594-conjugated goat anti-rabbit IgG antibody (for phospho-
Akt) (Molecular Probes Invitrogen). SYBR Green I (Cambrex,
Rockland, ME) was used for counterstaining of cell nuclei.
RNA Interference—Human DAP10/HCST (siDAP10, siG-
ENOME SMART pool M-005100-02-0005), human RAGE/
AGER (siRAGE, siGENOME SMART pool M-003625-02-
0005), and negative control (siCont, siGENOME nontargeting
siRNA pool 1, D-001210-01) siRNAs were purchased from
Thermo Scientific Dharmacon (Lafayette, CO). The siRNAs
(100 nM) were transfected using Lipofectamine RNAiMAX re-
agent (Invitrogen).
Statistical Analysis—Data are expressed as the means S.D.
We employed a simple pairwise comparison using Student’s t
test (two-tailed distribution with a two-sample equal variance).
Values of p 0.05 were considered statistically significant.
RESULTS
DAP10 Associates with RAGE via Its Transmembrane
Region—S100A8/A9, one of the 20 S100 proteins, plays a piv-
otal role in cutaneous inflammation with epidermal prolifera-
tion through RAGE binding (5, 18). In this study, we tried to
identify possible RAGE interacting receptor/adaptor proteins
that may facilitate this role by focusing on those related to
immune response and inflammation. An authentic approach in
which membrane proteins that co-precipitated with RAGE
were analyzed by LC-MS/MS did not yield any promising can-
didates (data not shown). In addition, Emmprin, which shares
the same ability to bind the S100A9 ligand (17), also did not
show interaction with RAGE (data not shown). We therefore
employed a candidate-based screening using inflammatory
receptors (TLR4, TNFR1, and TNFR2) andmembrane proteins
(c, gp130, and DAP10), which co-functioned with cytokine
receptors. As shown in Fig. 1A, only DAP10, a transmembrane
adaptor protein for NKG2D (26), was co-precipitated with
RAGE among the proteins examined. Interaction of RAGEwith
DAP10 was confirmed in different experimental settings, using
the already known binding between NKG2D and DAP10 as a
positive control (Fig. 1B). We also excluded the possibility that
DAP10 indirectly bound to RAGE via NKG2D because RAGE
did not show interaction with NKG2D (Fig. 1C). To investigate
the nature of binding between RAGE and DAP10, we used var-
ious deletion mutants of RAGE. Among the mutants, only a
RAGE variant lacking the transmembrane region (V-C1-C2)
failed in binding to DAP10 (Fig. 1D), indicating that both pro-
teins interact through the transmembrane domain.
DAP10 in its interaction with NKG2D is known to recruit
SH2 domain-containing adaptor molecules such as PI3K and
GRB2 (27, 28). We therefore examined whether these recruit-
ments could also occur downstreamof theRAGE-DAP10 inter-
action, and indeed we found that PI3K and GRB2 were co-pre-
cipitated with RAGE-DAP10. In addition, we found that GBR7,
another SH2-domain-containing adaptor protein, was also co-
precipitated with RAGE-DAP10 (Fig. 1E). Furthermore, the
recruitments of PI3K, GRB2, and GRB7 were all abrogated by
replacement of Tyr-86 with nonphosphorylatable Phe in the
cytoplasmic domain of DAP10 (Y86F) (Fig. 1F), as reported
previously (27). These results indicate that DAP10 may func-
tion as a transmembrane adaptor protein for RAGE (Fig. 1G).
Modulation of RAGE-triggered Signaling byDAP10—To gain
insight into the effect of DAP10 on RAGE signaling, we used an
artificial oligomerization system that enabled us to specifically
form RAGE-DAP10 heterodimers and also RAGE homomulti-
mers and homodimers for comparisons (Fig. 2, A and B, top
panel). In accordance with the results of our previous study
(21), multimerization and dimerization of RAGE alone resulted
in recruitment of PKC, TIRAP, and MyD88 with phosphory-
lation of PKC (Thr-560) and RAGE (Ser-391) in HEK293 cells.
PI3K, which linked to the activation of Akt, was recruited at a
remarkable level to the heterodimer of RAGE and DAP10
(RAGE-DAP10) and also at a lower level to the RAGE
homodimers (RAGE)2 and homomultimers (RAGE)M (Fig. 2B).
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FIGURE1.AssociationofDAP10withRAGE.A, screening for receptors interactingwithRAGE.HEK293Tcellswereco-transfectedwithRAGE (full, full-length)-3HA-
His6 and candidates (TLR4, TNFR1, TNFR2, DAP10, c, and gp130) tagged with 3HA-His6. Twenty four hours after transfection, cell extracts were prepared and
analyzedbyWesternblottingbothwith andwithoutprior IPusinganti-HA tagbeads for theexpressedRAGE.B, confirmationanalysis of theRAGE-DAP10 interaction
including a positive binding control, NKG2D-DAP10. A co-transfection experiment was performed as described in A using the combinations: DAP10–3FLAG-His6
withmembrane proteins (MP: TLR4, RAGE, and NKG2D) taggedwith 3HA-His6. C,NKG2D-independent binding of DAP10 to RAGE. Co-transfection and IP analysis
were performed as in A and B using the combinations of RAGE (full)-3HA-His6 withmembrane proteins (DAP10 and NKG2D) taggedwith 3FLAG-His6.D, identi-
ficationof an indispensable regionofRAGE for associationwithDAP10. Full-length (full) RAGEand its seven fragments (RAGE-Fs) taggedwithMyc-HA-FLAG-His6were
co-transfectedwithDAP10–3FLAG-His6 intoHEK293Tcells. Preparationof cell extracts and the subsequent IPexperimentswasperformedunder conditions similar
to those inA,B,andC.E, identificationofdownstreamadaptors forDAP10-RAGE.Simultaneous transfectionsofRAGE (full)-3HA-His6 andDAP10–3FLAG-His6with
SH2 domain-containing adaptors (SH2DAs: PI3K-p85, GRB2, GRB7, NCK1, NCK2, CRK, SOCS, SHC, and SHP2) tagged with 3Myc-His6 were performed. Twenty four
hoursafter transfection, cell extractswerepreparedandanalyzedbyWesternblottingbothwithandwithoutprior IPusinganti-HA tagbeads for theexpressedRAGE.
F,DAP10-dependent interactionof theadaptors (PI3K-p85,GRB2,andGRB7)withtheRAGE-DAP10receptorcomplex.SimultaneoustransfectionofRAGE(full)-3HA-
His6, DAP10–3FLAG-His6, andoneof the SH2DAs (PI3K-p85, GRB2, andGRB7)-3HA-His6 followedby IPwas performedunder conditions similar to those in Ewith
the inclusionofanonphosphorylatableDAP10 (Y86F is tyrosine86 replacedwithphenylalanine). Y86Fabrogates recruitmentof thedownstreamadaptorproteins.G,
schematic illustration of the interaction among RAGE, DAP10, and adaptor proteins.
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FIGURE 2. RAGE differential signal transduction with or without the presence of DAP10 association. A, schematic presentation of the procedure for
homomultimerization ((RAGE)M) (top) and homodimerization ((RAGE)2) (middle) of RAGE-cyt and heterodimerization (RAGE-DAP) of RAGE-cyt and DAP10-cyt
(bottom). B, recruitment of differential adaptor proteins with or without involvement of DAP10. HEK293T cells were transfected with DmrB-DmrB-RAGE-cyt-
3HA-His6 alone ((A) top), DmrA-DmrB-RAGE-cyt-3HA-His6, and DmrC-DmrB-RAGE-cyt-3FLAG-His6 ((A)middle), or DmrA-DmrB-RAGE-cyt-3HA-His6 and
DmrC-DmrB-DAP10-cyt-3FLAG-His6 ((A)bottom). Twenty four hours after transfection, the cellswere then treatedor not treatedwith conjugators (50 nM, 1 h)
(B/B homodimerizer or A/C heterodimerizer) and subjected toWestern blot analysis both with andwithout prior IP using anti-HA tag beads for the expressed
DmrB-DmrB-RAGE-cyt orDmrA-DmrB-RAGE-cyt.P-, phosphorylated.C,differential activationof downstreammoleculeswithorwithout involvementofDAP10
examined as in B. Ser-473 and Thr-308, phosphorylated Akt at the residues; Cl. Casp8, cleaved caspase 8; Bound, activated form. Bar graphs, quantified levels of
phosphorylated Akt and cleaved caspase 8 relative to tubulin. ImageJ (rsb.info.nih.gov) was used to compare the band density of Western blots. D, screening
for phosphorylated kinases in NHKs treated with the indicated siRNAs (100 nM, 48 h) and subsequent exposure to GST or S100A8/A9 (100 ng/ml, 24 h) using a
phospho-MAPK array (R&D Systems). E, time course experiments for the effect of siRNAs on Akt activation induced by S100A8/A9 (100 ng/ml) in NHKs. Bar
graphs, quantified levels of phosphorylated Akt and cleaved caspase 8 relative to tubulin.
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Laird et al. (29) reported that MyD88 also recruited PI3K to
some extent. This therefore may explain the occurrence of a
lower recruitment level of PI3K to RAGE homodimers and
homomultimers viaMyD88. In a following experiment, notably
theRAGE-DAP10heterodimer caused strong activation ofAkt,
although the RAGE homodimer and multimer resulted in
higher activations of caspase 8 and NF-B. Cdc42 and Rac1
were activated under both conditions, but the levels did not
show any appreciable difference for the comparisons of the
three different oligomerization systems (Fig. 2C). These results
indicate that the involvement of DAP10 leads to modulation of
RAGE-triggered signal transduction.
To study the possible role(s) of the physiological interaction
of RAGE andDAP10 in the activation of effector kinases, NHKs
were exposed to 100 ng/ml S100A8/A9, a physiological ligand
for RAGE. We found that Akt, especially Akt1 and Akt2, was
markedly phosphorylated, as demonstrated using a phosphoki-
nase array (Fig. 2D). When DAP10 was down-regulated with
siRNA, activation of Akt by S100A8/A9 was completely abro-
gated after 24 h of incubation (Fig. 2D). To examine the time
course more precisely, NHKs were exposed to 100 ng/ml
S100A8/A9 and analyzed by Western blotting. Akt was persis-
tently activated from5min to 24 h inNHKs.Additionally, when
DAP10 was down-regulated with siRNA, activation of Akt was
transient and nullified after 6 h (Fig. 2E). Similar results were
obtained in the transformed human keratinocyte cell lines
HaCaT and A431, with down-regulation of DAP10 (Fig. 3, A
and B), indicating that DAP10 is mainly involved in the persis-
tence of Akt activation.
To avoid the possibility that Akt activation by S100A8/A9
might have been produced through other receptors besides
RAGE, we alsomonitored the kinetics of S100A8/A9-mediated
Akt phosphorylation in cells in which RAGE expression was
silenced by siRNA. Similar to the effects of DAP10 siRNA treat-
ment, the use of RAGE siRNA resulted in abrogation of the
persistent activation of Akt. The abrogation by RAGE siRNA
was observed earlier, starting from60min, than that induced by
DAP10 siRNA, suggesting a more upstream role (Fig. 3, A and
B). In addition, similar activation kinetics of Akt was observed
in NHKs after exposure to another well established RAGE
ligand, S100B (data not shown). These results clearly indicate
that RAGE and DAP10 are essential for the persistence of Akt
activation.
Differential Response of Normal and Transformed Human
Keratinocytes to S100A8/A9—When exposed to a low concen-
tration of S100A8/A9 (100 ng/ml), both NHKs and the trans-
formed human keratinocyte cell lines, HaCaT andA431, exhib-
ited a similar strong and persistent activation of Akt without
activation of caspase 8 (Fig. 4A). Conversely, exposure to a high
concentration of S100A8/A9 (10 g/ml) caused NHKs to show
minimal activation of Akt with strong activation of caspase 8,
although HaCaT and A431 cells continued to show predomi-
FIGURE 3. Effects of siRNAs on S100A8/A9-mediated activation of Akt. A, inhibitory effects of siRNAs against DAP10 and RAGE. Seventy two hours after
transfectionwith a negative control siRNA (control), DAP10 siRNA, andRAGE siRNAs, each at 100nM, the treated cellswere harvested andexaminedbyWestern
blot analysis. B, time course experiments for the effect of siRNAs on Akt activation induced by S100A8/A9 (100 ng/ml) in NHKs, HaCaT, and A451 cells. Forty
eighthours after transfectionwith the indicated siRNAs (Control, DAP10, andRAGE) inNHKs, the cellswere treatedwith S100A8/A9 (100ng/ml) for the indicated
periods.
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nant activation of Akt (Fig. 4B). With these results, we further
extended our study to investigate possible signaling machin-
ery(ies) that could have caused the cells to respond differently
toward the treatment with S100A8/A9. Treatment with 100
ng/ml S100A8/A9 for 24 h in NHKs induced the strong activa-
tion of Akt, together with an increase in phosphorylation of
DAP10 and recruitment of PI3K, whereas 10g/ml S100A8/A9
led to activation of caspase 8. This was followed by a higher
phosphorylation level of PKC, its linked RAGE phosphoryla-
tion, and increased recruitment of TIRAP (Fig. 4C). Interest-
ingly, exposure of 10 g/ml S100A8/A9 in both HaCaT and
A431 showed a RAGE-triggered signaling profile similar to that
observed in NHKs exposed to 100 ng/ml but not 10 g/ml
S100A8/A9 (Fig. 4D). In accordance to these signal transduc-
tion profiles, 100 ng/ml S100A8/A9 stimulated the growth of
NHKs, but 10g/ml S100A8/A9 suppressed it. For HaCaT and
A431 cells, even 10 g/ml S100A8/A9 stimulated growth (Fig.
5A). In addition, we found that pharmacological inhibition of
Akt signaling using an Akt inhibitor markedly abrogated
growth enhancement in NHKs with low concentration of
S100A8/A9 (100 ng/ml) and inHaCaT andA431 cells with both
low (100 ng/ml) and high (10 g/ml) concentrations of
S100A8/A9 (Fig. 5A). Next, we found that high (10g/ml) con-
centration of S100A8/A9 actually induced apoptosis in NHKs
but not in HaCaT and A431 cells. However, application of the
Akt inhibitor resulted in induction of apoptosis by a high con-
centration of S100A8/A9 in HaCaT and A431 cells (Fig. 5B).
Correspondingly, application of the Akt inhibitor caused acti-
vation of caspase 8 by a high concentration of S100A8/A9 in
HaCaT and A431 cells, similar to that in NHKs without Akt
FIGURE 4. S100A8/A9-triggered signaling is differentially regulated in NHKs, HaCaT cells, and A431 cells. A, time-dependent activation of Akt and
cleavedcaspase8 (Cl. Casp8) by S100A8/A9at a lowdose, 100ng/ml, or (B) at ahighdose, 10g/ml.H2O2 (500M, 3h)wasusedas apositive control.Bar graphs,
quantified levels of phosphorylated Akt and cleaved caspase 8 relative to tubulin. C, activation of adaptor and downstream signaling proteins by S100A8/A9.
Twenty four hours after application of S100A8/A9 (0, 0.1, and 10 g/ml), cell extracts were analyzed by Western blotting both with and without prior IP of
endogenous RAGE using biotinylated anti-RAGE and streptavidin beads.D, activation of adaptor and downstream signaling proteins by a high concentration
of S100A8/A9 (10 g/ml) among different cell lines (NHKs, HaCaT cells, and A431 cells).
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inhibitor (Fig. 5C). Thus, Akt plays a critical role in S100A8/A9-
mediated regulation of cellular proliferation and apoptosis.
To better understand the differential response of normal and
transformed human keratinocytes to a high concentration of
S100A8/A9 (10 g/ml) in correlation with DAP10, the expres-
sion levels of endogenous DAP10 were examined. We found
that endogenous DAP10 was remarkably overexpressed in
HaCaT and A431 cells (Fig. 6A). This up-regulation of DAP10
was not affected by the presence or absence of nutritional sup-
plements in the cultures (HKGS for NHKs; FBS for HaCaT and
A431 cells). When DAP10 was down-regulated by siRNA, acti-
vation ofAktwas abrogated, and caspase 8was activated in both
lines exposed to 10g/ml S100A8/A9. Phosphorylation of both
RAGE and PKC was eventually up-regulated followed by
recruitment of TIRAP and suppression ofDAP10-PI3Kbinding
(Fig. 6B). Moreover, down-regulation of DAP10 in HaCaT and
A431 cells by siRNA in turn sensitized the cells to apoptosis by
high concentrations of S100A8/A9 (Fig. 7A). However, the
forced expression of a foreign DAP10 in NHKs resulted in a
higher resistance to apoptosis by a high concentration of
S100A8/A9 (Fig. 7B). These observations in cell resistance and
apoptosis patterns of DAP10 down-regulatedHaCaT andA431
cells, and in DAP10 the up-regulated NHKs were similar to
those seen inNHKs and in transformed cells, respectively, indi-
cating that the differential response of normal and transformed
human keratinocytes to different concentrations of S100A8/A9
is due to the extent of DAP10 involvement in RAGE signaling.
Overexpression of DAP10 in the Psoriatic Human Epidermis—
To gain insight into the biological significance of the involve-
ment of DAP10, we analyzed the normal human epidermis and
psoriatic human epidermis by immunohistochemistry. In
accordance with our previous report, S100A8/A9 was overex-
pressed in the lesional epidermis of patients with psoriasis vul-
garis and pustular psoriasis (Fig. 8A). DAP10 was remarkably
overexpressed in two different cases of psoriatic vulgaris and
pustular psoriasis (Fig. 8B). A high level of phosphorylated Akt
was also observed in the psoriatic epidermis. Finally, among the
various growth factors and inflammatory cytokines applied in
FIGURE 5. Differential response to S100A8/A9 among NHKs, HaCaT cells, and A431 cells. A, stimulation of DNA synthesis by S100A8/A9. The cells (NHKs
(left), HaCaT cells (middle), and A431 cells (right)) were treated with S100A8/A9 (0, 0.1, and 10 g/ml) for 24 h, and [3H]thymidine (1 Ci/ml) was added to the
cultures 1 h prior to harvesting of cells in the presence or absence of an Akt inhibitor (10 M) (*, p  0.05). B, induction of apoptosis by S100A8/A9 (24 h).
FITC-labeled annexin V was added to the cultures 1 h prior to fluorescence counting of cells (*, p  0.05). C, activation of cleaved caspase 8 (Cl. Casp8) by
S100A8/A9 (24 h). The experiments shown in B and Cwere performed under conditions similar to those described in A.
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this study, only IL-22 remarkably inducedDAP10 inNHKs (Fig. 9,
A and B). Pretreatment with IL-22 protected NHKs against, to
some degree, the apoptosis induced by a high concentration of
S100A8/A9 (Fig. 9C), therefore indicating a certain level of
involvement of IL-22 in the DAP10 overexpression.
DISCUSSION
In this study, we showed that DAP10 interacts with RAGE.
DAP10 is known to be a transmembrane adaptor protein for the
NKG2D expressed in NK cells. Both DAP10 and NKG2D are
also expressed on the surface of various types of cancer cells of
epithelial origin (30). NKG2D recognizes nonclassical MHC
class I antigens on the surface of cancer cells and transduces a
signal via DAP10, leading to increased survival and prolifera-
tion (31). NKG2D and DAP10 interact through their trans-
membrane domain (26, 32). This method of interaction is
shared not only by other known receptor proteins such as
Sirp-b1 (33), Cd3001b (34), and Siglec-15 (35) but also byRAGE
(Fig. 1D). Different from other receptor proteins where a neg-
atively charged aspartic acid residue in the transmembrane
region of DAP10 binds to a positively charged lysine, in RAGE,
there is no positively charged residue in the transmembrane
domain. At present, we cannot exclude the possibility that an
unknown protein mediates the interaction between RAGE and
DAP10. The use of a direct binding assay has been hampered by
the extreme difficulty of purifying the two membrane proteins
independently.
RAGE is known to transduce differential signals depending
on the ligand concentration in certain biological contexts. For
example, S100B promotes neurite outgrowth and protects neu-
rons against oxidative stress at nanomolar levels, although it
induces neuronal degeneration at micromolar levels (36). In
another report, growth of NHKs was stimulated at nanomolar
concentrations, but NHKs underwent apoptosis at micromolar
concentrations of S100A8/A9 (Fig. 5) (18). These differential
outcomes are at least partly due to the different intracellular
signaling pathways downstream of RAGE (7, 8). In this study,
we showed that DAP10 is involved in the selection of down-
stream signal transduction pathways. In an artificial multi-
merization system (Fig. 2, A–C), homomultimerization of
RAGE led to activation of caspase 8, although heterodimeriza-
tion of RAGE and DAP10 resulted in augmentation of growth/
survival signals. In NHKs, S100A8/A9 appeared to induce het-
erodimerization of RAGE and DAP10 at lower concentrations
but facilitated homomultimerization of RAGE at higher con-
centrations (Fig. 4C). However, transformed cells such as
HaCaT and A431 cells, in which DAP10 was overexpressed
(Fig. 6A), preferentially formed heterodimers even at a higher
concentration of S100A8/A9 (Fig. 4D) because of the abun-
dance ofDAP10. Thus,DAP10 at least partly determines down-
stream signaling from ligand-activated RAGE.
InNHKs,DAP10 efficiently recruited PI3Kupon binding to a
low concentration (100 ng/ml) of S100A8/A9-stimulated
RAGE and persistently activated Akt (Fig. 4C), leading to better
survival (Fig. 5A). Persistent activation of Akt was also observed
when NHKs were exposed to S100A11 (37). When DAP10 was
down-regulated in NHKs, Akt was still activated but only tran-
siently (Figs. 2E and 3, A and B), indicating that DAP10 is
important for sustained Akt activation. It is known that a tyro-
sine residue (Tyr-86) in the YXXM motif of the intracellular
domain of DAP10 recruits PI3K (p85) when phosphorylated
(28).We confirmed that PI3K binds avidly to the RAGE-DAP10
complex (Figs. 1, E and F, and 2B). As we reported previously,
RAGE has another adaptor protein pathway, i.e. TIRAP and
MyD88 (21). Because MyD88 has the capacity to recruit PI3K
(29), the observed transient activation of Akt in DAP10-de-
FIGURE 6.Down-regulation of DAP10modulates RAGE-triggered signal-
ing. A, increased expression of endogenous DAP10 in HaCaT and A431 cells
compared with that in NHKs. The cells were cultured with or without supple-
ments (HKGS for NHKs and FBS for HaCaT andA431 cells). Expression levels of
endogenous DAP10 were determined by Western blot analysis. B, activation
of adaptor and downstream signaling molecules upon down-regulation of
DAP10 in HaCaT and A431 cells. Forty eight hours after transfection with 100
nM siRNAs, the cells were further incubated with GST or S100A8/A9 at 10
g/ml for 24 h. Cell extracts were then prepared and analyzed by Western
blottingwith orwithout prior IP of endogenous RAGEusingbiotinylated anti-
RAGE and streptavidin beads. Bar graphs, quantified levels of phosphorylated
Akt and Cl. Casp8 relative to tubulin.
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pleted cells likely occurred through this pathway (Figs. 2E and
3B).
As reported previously (21), PKC is essential for RAGE-
triggered signal transduction. PKC is activated by autophos-
phorylation of Thr-560 at the C-terminal side (38). Homo-
dimerization and homomultimerization of RAGE resulted in
autophosphorylation of PKC (Thr-560) (Fig. 2B). Homodi-
merization and homomultimerization of RAGE probably led to
mutual phosphorylation of associated PKC, and the activated
PKC, in turn, phosphorylated Ser-391 of RAGE. The abundant
DAP10 inhibited the homodimerization and homomultim-
erization and hence phosphorylation of Ser-391 of RAGE (Fig.
2B). Because phosphorylated Ser-391 is essential for the
recruitment of TIRAP/MyD88 (21), the involvement of DAP10
in RAGE-triggered signaling leads to abrogation of caspase 8
activation and alternatively to sustainedAkt activation (Fig. 2,C
and E).
We do not think that the S100A8/A9-induced activation of
Akt that is observed in various types of cells is solely mediated
by RAGE-DAP10. Vogl et al. (39) reported that S100A8/A9
binds to TLR4, and we showed that Emmprin also functions as
a receptor for S100A8/A9 (17). Akt is a downstream signal
mediator for TLR4 and Emmprin (29, 40). InNHKs, the expres-
sion level of TLR4 was very low, but Emmprin was expressed at
an appreciable level as assayed by quantitative RT-PCR (data
not shown). In general, the expression profiles of RAGE,
DAP10, TLR4, and Emmprin vary greatly depending on the cell
type (data not shown). The partially overlapping functional
interference among receptors and adaptor proteins, together
with the variable expression profiles of the involved proteins,
includes a complex signal processing unit.
IL-22 produced by skin-infiltrating lymphocytes is thought
to be involved in the initiation and/or maintenance of psoriasis
(41, 42). Application of IL-22 to an in vitro organotypic skin
FIGURE 7.DAP10-related cell survival. A, sensitization of HaCaT and A431 cells to 10g/ml S100A8/A9-induced apoptosis by down-regulation of DAP10 (*,
p 0.05). The cells (HaCaT cells (left) andA431 cells (right)) were treatedwith siRNAs for 48 h, and apoptotic rateswere determined using FITC-labeled annexin
V. B, effects of forced expression of DAP10 on S100A8/A9-mediated apoptotic cell death. NHKs were transiently transfected with a plasmid expressing red
fluorescence protein (RFP; negative control) or DAP10 tagged with C-terminal 3FLAG-His6. After incubation for 48 h, the cells were treated with S100A8/A9
(10 g/ml) for 24 h and then fixed with 4% paraformaldehyde. Sample slides were processed with a click-it TUNEL Alexa Fluor Imaging kit (Molecular Probes
Invitrogen) for detecting apoptotic cells (green). The expression of DAP10 was visualized by indirect immunostaining with anti-FLAG antibody (red). Nuclei
were stained with Hoechst 33342 (blue). Scale bar, 20 m.
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model resulted in deterioration in terminal differentiation of
the epidermis and hyperplastic epidermis with a reduced gran-
ular layer, which is often observed in psoriatic lesions (43, 44).
Overexpression of IL-22 led to psoriasis-like hyperplasia in in
vivomouse skin (44). Injection of IL-23 intomouse skin also led
to epidermal hyperplasia, which was abrogated in IL-22/
mice and in mice treated with an antibody against IL-22 (45,
46). Van Belle et al. (47) showed that IL-22 is functionally
involved in the pathogenesis of psoriasis with pustules induced
by the TLR7/8 agonist imiquimod. As shown in Fig. 9, A and B,
IL-22 induced a remarkable level of DAP10 in NHKs. It is well
known that IL-22 is a potent inducer of S100A8/A9 (48, 49).
Therefore, it is conceivable that an overexpression of S100A8/
A9 and DAP10, induced at least in part by IL-22, plays a pivotal
role in the pathogenesis of psoriasis.
Activated RAGE-DAP10 recruited not only PI3K but also
GRB2 andGRB7 (Fig. 1,E and F). An interaction betweenGRB7
and DAP10 was newly found in this study. GRB2 and GRB7 are
known to function as adaptor proteins for ErbB2 (50, 51) and
lead to cellular proliferation via the activation of Ras (52, 53). It
is possible that GRB2 andGRB7 are involved in hyperprolifera-
tion of the epidermis in psoriatic lesions.
Accumulating evidence indicates that IL-22 is involved in
cancer progression. IL-22 produced by infiltrating T cells and
cancer cells themselves stimulates cell proliferation and en-
hances survival (54, 55). In addition, S100A8/A9, RAGE,
and DAP10 are often overexpressed in various types of cancer
(30, 56–59). The present findings regarding the functional
interaction between RAGE and DAP10 may also be relevant to
cancer progression.
Recently, IL-1R antagonists such as IL-1Ra and IL-36Ra have
attracted attention due to their potential roles in the pathogen-
esis of pustular psoriasis (60). Mutation in IL-1Ra and deletion
in IL-36Ra have been observed in patients with pustular psori-
asis (61–64). A functional defect in the antagonists caused a
failure in the control of inflammatory signals from the IL-1
receptor family. We previously reported that production of
IL-1F9 (IL-36, an IL-36R agonist) was remarkably enhanced
by S100A8/A9 in NHKs and that IL-1F9 in turn induced
S100A8/A9 (positive feedback) (18). In IL-36Ra-deficient
FIGURE8.Highlyup-regulatedexpressionofDAP10 in theepidermisofpsoriatic lesions.A, immunohistochemistry analysis for a RAGE ligand, S100A8/A9
heterodimer (red), in psoriatic lesions. S100A8/A9 was detected in keratinocytes and infiltrating inflammatory cells both in psoriasis vulgaris and pustular
psoriasis. B, detection of RAGE (red), DAP10 (green), and phospho-Akt (red) in skin sections prepared from normal and psoriatic skin. Nuclei were stained with
SYBR Green. Bars in A and B, 100 m. C, induction of DAP10 by IL-22 applied to NHKs for 24 h.
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patients, overproduction of S100A8/A9 may trigger an uncon-
trolled positive feedback mechanism for inflammation and
hyperproliferation. In addition, we observed that activated
RAGE leads to the induction of IL-1R agonists such as IL-1
and IL-1 (21).
In conclusion, we found that DAP10 is critically involved in
RAGE-mediated survival signaling upon S100A8/A9 binding
via the sustained activation of Akt. Both the concentrations of
ligands and the expression levels of DAP10 affected the signal-
ing pathways downstream from RAGE, but in a different man-
ner. Such differential signaling has been observed in psoriatic
epidermal cells and cancer cells but not in their normal coun-
terparts, and thus has been implicated in the pathogenesis of
these conditions.We hope that our findings will lead to a better
understanding of the physiological and pathological conditions
of keratinocytes and the development of therapeutic measures
against various skin diseases.
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